ubmslateCN-logo-ubm

CN Mobile Logo

Topics:

News

ASCO 2016 Genitourinary Cancers Symposium

Cancer Network presents exclusive coverage from the American Society of Clinical Oncology (ASCO) 2016 Genitourinary Cancers Symposium, held January 7–9 in San Francisco. We’ll bring you reports as we cover the latest research, trials, scientific advances, and controversies that are changing the way genitourinary cancers are managed and treated.

News

Researchers have uncovered the mechanism that causes about one-third of myeloma cases associated with Gaucher disease, showing that myeloma cells target certain lipids that are elevated in the blood of a subset of patients.

Despite similar survival, multiple myeloma patients treated with lenalidomide experienced lower rates of neurologic toxicity than those treated with thalidomide.

Young breast cancer patients increasingly undergo genetic testing for BRCA1 and BRCA2 mutations. Testing also appears to influence surgical treatment decisions.

High expression levels of EGFR ligands epiregulin and amphiregulin are associated with increased benefit from panitumumab in patients with RAS wildtype advanced colorectal cancer.

A number of clinical and sociodemographic factors, including age and gender, were found to be independently associated with fatigue and depression among cancer patients who were treated with hematopoietic cell transplantation.

The 2012 change in guidelines regarding PSAtesting for prostate cancer had a different effect on testing rates depending on which physician specialty was doing the testing.

Some adult-onset cancer survivors have an increased risk of developing cardiovascular disease later in life compared to noncancer controls.

Pages

Subscribe to News on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.